Dr. Mena Farag joins Dr. Eduardo de Pablo-Fernández to discuss how proenkephalin and other biomarkers can help monitor the earliest stages of Huntington's disease decades before the onset of motor symptoms.

<a href="https://education.movementdisorders.org/Detail/1074/Journal-CME-41-01:-Cerebrospinal-Fluid-Proenkephalin-Predicts-Striatal-Atrophy-Decades-before-Clinical-Motor-Diagnosis-in-Huntington's-Disease">Journal CME</a> is available until February 11, 2027
<br />

<a href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.70062">Read the article.</a>

Dr. Mena Farag joins Dr. Eduardo de Pablo-Fernández to discuss how proenkephalin and other biomarkers can help monitor the earliest stages of Huntington's disease decades before the onset of motor symptoms. Journal CME is available until February 11, 2027 Read the article.

Dr. Mena Farag joins Dr. Eduardo de Pablo-Fernández to discuss how proenkephalin and other biomarkers can help monitor the earliest stages of Huntington's disease decades before the onset of motor symptoms.

<a href="https://education.movementdisorders.org/Detail/1074/Journal-CME-41-01:-Cerebrospinal-Fluid-Proenkephalin-Predicts-Striatal-Atrophy-Decades-before-Clinical-Motor-Diagnosis-in-Huntington's-Disease" rel="noopener noreferrer">Journal CME</a> is available until February 11, 2027
<br>

<a href="https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.70062" rel="noopener noreferrer">Read the article.</a>

CSF proenkephalin as a biomarker for premotor Huntington's disease

Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.

Share CSF proenkephalin as a biomarker for premotor Huntington's disease

Sign up to save your podcasts

CSF proenkephalin as a biomarker for premotor Huntington's disease

CSF proenkephalin as a biomarker for premotor Huntington's disease